Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)
4.43 -0.59 (-11.75%) 11:53 ET [NYSE]
4.42 x 400 4.43 x 200
Realtime by (Cboe BZX)
4.42 x 400 4.43 x 200
Realtime 4.98 -0.04 (-0.80%) 09:29 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.48
Day High
4.90
Open 4.89
Previous Close 5.02 5.02
Volume 1,062,884 1,062,884
Avg Vol 2,249,792 2,249,792
Stochastic %K 8.83% 8.83%
Weighted Alpha -57.57 -57.57
5-Day Change -1.15 (-20.28%) -1.15 (-20.28%)
52-Week Range 3.96 - 9.87 3.96 - 9.87
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,847,029
  • Shares Outstanding, K 367,934
  • Annual Sales, $ 9,625 M
  • Annual Income, $ -46,000 K
  • EBIT $ 2,652 M
  • EBITDA $ 4,056 M
  • 60-Month Beta 0.43
  • Price/Sales 0.18
  • Price/Cash Flow 0.62
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 65.73% ( -58.11%)
  • Historical Volatility 52.79%
  • IV Percentile 61%
  • IV Rank 20.29%
  • IV High 177.43% on 07/24/24
  • IV Low 37.30% on 05/24/24
  • Put/Call Vol Ratio 39.14
  • Today's Volume 3,171
  • Volume Avg (30-Day) 3,295
  • Put/Call OI Ratio 2.51
  • Today's Open Interest 192,460
  • Open Int (30-Day) 184,159

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.46
  • Number of Estimates 5
  • High Estimate 3.76
  • Low Estimate 0.78
  • Prior Year 0.59
  • Growth Rate Est. (year over year) +147.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.40 +2.73%
on 04/09/25
Period Open: 7.00
7.45 -39.33%
on 03/25/25
-2.48 (-35.43%)
since 03/10/25
3-Month
4.40 +2.73%
on 04/09/25
Period Open: 7.88
8.02 -43.64%
on 01/24/25
-3.36 (-42.64%)
since 01/10/25
52-Week
3.96 +14.14%
on 07/24/24
Period Open: 8.92
9.87 -54.20%
on 04/11/24
-4.40 (-49.33%)
since 04/10/24

Most Recent Stories

More News
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris

LAVAL, QC / ACCESS Newswire / April 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that it has signed a letter of intent with the pan-Canadian...

BHC.TO : 6.30 (-10.89%)
BHC : 4.43 (-11.75%)
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, diagnosed...

BHC.TO : 6.30 (-10.89%)
BHC : 4.43 (-11.75%)
Bausch Health to Announce First Quarter Results on April 30

LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health...

BHC.TO : 6.30 (-10.89%)
BHC : 4.43 (-11.75%)
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes

LAVAL, QC / ACCESS Newswire / March 25, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has priced its previously announced offering (the...

BHC.TO : 6.30 (-10.89%)
BHC : 4.43 (-11.75%)
Bausch Health Announces Conditional Redemption of Senior Notes

LAVAL, QC / ACCESS Newswire / March 21, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that (i) it has delivered conditional notices of redemption...

BHC.TO : 6.30 (-10.89%)
BHC : 4.43 (-11.75%)
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities

Transaction is part of a broader refinancing initiative aimed at opportunistically accessing capital markets to address near- and mid-term maturities

BHC.TO : 6.30 (-10.89%)
BHC : 4.43 (-11.75%)
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes

LAVAL, QC / ACCESS Newswire / March 19, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has launched an offering (the "Offering") of $4.0...

BHC.TO : 6.30 (-10.89%)
BHC : 4.43 (-11.75%)
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan

LAVAL, QC / ACCESS Newswire / March 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better...

BHC.TO : 6.30 (-10.89%)
BHC : 4.43 (-11.75%)
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales

Shares of Bausch Health Companies Inc. BHC gained 2.36% after the company reported better-than-expected fourth-quarter results. Shares also gained 7.8% in aftermarket trading.Adjusted earnings per share...

IMCR : 25.44 (-2.60%)
PCRX : 22.75 (-11.96%)
BHC : 4.43 (-11.75%)
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises

The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.

VSS : 109.38 (-1.45%)
VXUS : 57.99 (-2.54%)
PPH : 79.29 (-4.52%)
BLCO : 11.13 (-11.17%)
BHC : 4.43 (-11.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic...

See More

Key Turning Points

3rd Resistance Point 5.98
2nd Resistance Point 5.54
1st Resistance Point 5.28
Last Price 4.43
1st Support Level 4.58
2nd Support Level 4.14
3rd Support Level 3.88

See More

52-Week High 9.87
Fibonacci 61.8% 7.61
Fibonacci 50% 6.91
Fibonacci 38.2% 6.22
Last Price 4.43
52-Week Low 3.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar